The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections.
about
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusPrevention of wear particle-induced osteolysis by a novel V-ATPase inhibitor saliphenylhalamide through inhibition of osteoclast bone resorptionInhibition of influenza virus replication by targeting broad host cell pathwaysAkt inhibitor MK2206 prevents influenza pH1N1 virus infection in vitro.Interplay between influenza A virus and host factors: targets for antiviral intervention.Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses.Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection.Suppression of influenza A virus replication in human lung epithelial cells by noncytotoxic concentrations bafilomycin A1.Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.The GEF1 proton-chloride exchanger affects tombusvirus replication via regulation of copper metabolism in yeastAnticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected miceInhibition by cellular vacuolar ATPase impairs human papillomavirus uncoating and infectionInfluenza virus-host interactomes as a basis for antiviral drug development.Novel techniques in the development of osteoporosis drug therapy: the osteoclast ruffled-border vacuolar H(+)-ATPase as an emerging target.Maoto, a Traditional Japanese Herbal Medicine, Inhibits Uncoating of Influenza Virus.Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins.
P2860
Q28084005-276320C3-47E8-43AF-ACFB-919F9E2B6372Q28482246-3D9F7EE6-FF97-45F2-96F0-BB69614C1D74Q28543978-0235DE81-EE61-455F-BEC1-7E547C5622F4Q30361598-687DF25A-7588-4B64-A5E5-4325FD470F4CQ30375026-1937C99F-4C75-42CE-B60C-838A0220386BQ30432662-E4C42D2D-A6CA-474E-A36C-22FF934A51F8Q30448355-B21E470B-EE79-4624-A6B5-6FC8BB6DB49EQ35115803-27876C29-AD28-4E44-AA37-269804094BCAQ35605579-CFFD816B-BA11-41F4-9E80-588BDDABDB1AQ36559787-80687DB5-46DE-441C-8A64-B671D8571F7CQ37062096-7928D774-2221-49B4-96E7-A79900642133Q37712999-742AC69D-05E3-4A81-8AF1-4959478A0B6FQ37737812-6C2D7A25-4EBB-4F7C-B7DF-8AC2547C9383Q38205860-48C04E87-99C3-429F-A2BC-AB53B9D084CEQ40042197-911E061B-1F9D-4D6B-ADF7-EA217BC2B9A8Q41930599-C2B2DB92-2516-4654-8E79-E81B076D1738
P2860
The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The proton translocation domai ...... influenza A virus infections.
@ast
The proton translocation domai ...... influenza A virus infections.
@en
type
label
The proton translocation domai ...... influenza A virus infections.
@ast
The proton translocation domai ...... influenza A virus infections.
@en
prefLabel
The proton translocation domai ...... influenza A virus infections.
@ast
The proton translocation domai ...... influenza A virus infections.
@en
P2093
P2860
P1476
The proton translocation domai ...... influenza A virus infections.
@en
P2093
Christian Kittel
Claude P Muller
Denis E Kainov
Elisabeth Samm
Jef K De Brabander
Karim El Bakkouri
Konstantin H Müller
Xavier Saelens
P2860
P304
P356
10.1111/J.1476-5381.2011.01346.X
P407
P577
2011-09-01T00:00:00Z